Latest Medical Technology from Bio-Medicine.Org

NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation

Tue, 21 May 2013 03:31:29 MST

MOUNT PROSPECT, Ill. , May 21, 2013 /PRNewswire-USNewswire/ -- Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy ® (NABP ® ) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation. NABP intends to launc...

Concord Medical Reports First Quarter 2013 Financial Results

Tue, 21 May 2013 03:07:29 MST

BEIJING, May 21, 2013 /- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today reported its unaudited consolidated financial results for the first quar...

NxStage Announces New Agreements with DaVita

Tue, 21 May 2013 02:24:47 MST

LAWRENCE, Mass. , May 21, 2013 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that it has entered into new agreements covering its supply of home, critical care and in-center products to DaVita, the kidney care division of DaVita Healthcare Partners Inc. (Logo: http://photos.prnewswire.com/prnh/2011...

New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System

Tue, 21 May 2013 02:12:05 MST

SAN FRANCISCO , May 21, 2013 /- New data released today at the annual meeting of the American Psychiatric Association show that the NeuroStar TMS Therapy System ® induced statistically and clinically meaningful response and remission in patients with Major Depressive Disorder (MDD) during the acute phase of therapy, which were maintained through one year of treatment. ...

Valeant Pharmaceuticals Announces 2013 Annual Meeting Results

Tue, 21 May 2013 02:11:45 MST

LAVAL, Quebec , May 21, 2013 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today announced the election of ten directors nominated at its 2013 annual meeting of shareholders today. The detailed results of the vote for the election of directors are set out below: NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,...

Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results

Tue, 21 May 2013 01:49:11 MST

RONKONKOMA, N.Y., May 21, 2013 /- Lakeland Industries, Inc. (NASDAQ: LAKE ), a leading global manufacturer of industrial protective clothing for industry, municipalities, healthcare and first responders on the federal, state and local levels, today announced that the Company accepted a commitment letter from a bank for a Senior Credit Facility subject to certain terms and con...

Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand

Tue, 21 May 2013 01:49:03 MST

EAST TAUNTON, Massachusetts , 21. Mai 2013 /- Der Vorstand der Orthopaedic Synergy Inc. („OSI"), die die Firmen OMNIlife science® Inc., Enztec Ltd. und Praxim SA zu ihren Tochtergesellschaften zählt, hat zwei neue, erfahrene Mitglieder in die Führungsriege gewählt. Guy Mayer , eine erfahrene Führungspersönlichkeit aus der Orthopädi...

Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference

Tue, 21 May 2013 01:48:55 MST

LA JOLLA, Calif. , May 21, 2013 /- Regulus Therapeutics Inc . ( NASDAQ: RGLS ), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Garry E. Menzel , Ph.D., Chief Operating Officer and Executive Vice President, Finance, will present a company overview at the Deutsche Bank 38th Annual Healthca...

Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva

Tue, 21 May 2013 01:06:29 MST

EAST TAUNTON, Massachusetts , 21 de mayo de 2013 /- La junta directiva de Orthopaedic Synergy, Inc. ("OSI"), cuyas compañías filiales incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, SA, han seleccionado a dos directores experimentados para su junta. Guy Mayer, un ejecutivo ortopédico experimentado, será vicepresidente de la junta d...

Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year

Tue, 21 May 2013 01:06:21 MST

CINCINNATI , May 21, 2013 /- Tom Daulton, CEO of Mammotome, a division of Devicor Medical Products, has been named Dealmaker of the Year by the Cincinnati chapter of the Association for Corporate Growth (ACG). Daulton, who was nominated by another local top executive who is also a breast cancer survivor, led the purchase of the Mammotome® brand from Ethicon Endo-Sur...

RenovoRx Named Winner of 2013 TiE50 "Top Startup"

Tue, 21 May 2013 01:06:14 MST

SAN JOSE, Calif. , May 21, 2013 /- RenovoRx ( www.renovorx.com ) has been named Winner of the prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, the world's largest annual convention for entrepreneurs, for its innovation, strong management team and quality of entrepreneurial ideas. RenovoRx was honored on Saturday, May 18 th at the Santa Clara Convention Center. T...

LCA-Vision Reports on Annual Meeting of Stockholders

Tue, 21 May 2013 10:57:54 MST

CINCINNATI , May 21, 2013 /- LCA-Vision Inc. (NASDAQ: LCAV ), a leading provider of laser vision correction services under the Lasik Plus ® brand, announces that all nominees to the company's Board of Directors were re-elected to one-year terms at today's annual meeting of stockholders. These Directors are: William F. Bahl , co-founder and President of Bah...

Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia

Tue, 21 May 2013 10:57:47 MST

LONDON and PHILADELPHIA , May 21, 2013 /- On its tenth anniversary Pi2 introduced its new corporate image and impressive new product developments at the Special Libraries Association PHTD meeting in Philadelphia . "After ten years of unerring focus on product literature databases and workflow solutions for the pharmaceutical industry we felt the need to mark the occasion...

Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer

Tue, 21 May 2013 09:41:29 MST

PRINCETON, N.J. , May 21, 2013 /- Kepner-Tregoe (KT), the global capability development and consulting company, today announced that 13-year veteran Chris Geraghty has been appointed Chief Executive Officer. Geraghty's experience includes more than 20 years serving the industrial sector, holding numerous senior management positions with manufacturing organizations. He succeed...

Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show

Tue, 21 May 2013 07:49:09 MST

TEANECK, N.J. , May 21, 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated for Sept 17-19 in NJ has attracted the greatest number of "Emerging" small molecule biotech company chemists ever, reports its President, Mark Alexay . "No one saw this coming", commented Alexay. "But suddenly everyone plans to attend this year. The show's s...

The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy

Tue, 21 May 2013 07:00:54 MST

CHICAGO , May 21, 2013 /- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Actavis, Inc.'s (NYSE: ACT ), BP plc (NYSE: BP ), Total SA (NYSE: TOT ), Petrobras (NYSE: PBR ) and Devon Ene...

Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer

Tue, 21 May 2013 07:00:40 MST

BURLINGTON, Mass. , May 21, 2013 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the effect of an emerging agent on key efficacy endpoints, including overall survival and time to disease progression, has the most influence over surveyed U.S. and European oncologists' prescribing decisions for...

Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace

Tue, 21 May 2013 07:00:33 MST

FLORHAM PARK, N.J. , May 21, 2013 /- Armada Health Care (Armada) is pleased to announce the launch of the new Armada corporate website ( www.armadahealthcare.com ). This new website was designed to clearly communicate Armada's unique and first-to-market services and its position as the leading health care service company focused on the specialty pharmacy industry. Th...

IsoRay Announces A New International Distributor For Greece

Tue, 21 May 2013 06:24:53 MST

RICHLAND, Wash. , May 21, 2013 /- IsoRay, Inc. (AMEX: ISR ), ( http://www.isoray.com/ ), announced today that it has entered into an exclusive international distribution agreement with IASIS Medical for the sale of IsoRay's complete product line in Greece . IsoRay is a medical technology company and innovator in seed brachytherapy and medical radioisotope applications f...

Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms

Tue, 21 May 2013 06:12:54 MST

SANTA CLARA, Calif. , May 21, 2013 /- Cephasonics, a technology-innovation leader with a game-changing embedded-ultrasound platform, today announced the introduction of the cQuest Ultrasound SDK™ Client/Server Toolkit that allows complete network-based communications with all cQuest Ultrasound™ hardware platforms. Cephasonics will demonstrate its latest embedded-...